Dr Sean McBride on the PCCTC-Managed AASUR Trial in High-Risk Prostate Cancer

Mar 16

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

First Quadruplet Therapy Regimen Shows Promise for Men with High-Volume Metastatic APMN Prostate Cancer

Advancing the Standard: How the PCCTC Led the Science at the 2026 ASCO GU Symposium and Forged New Paths for Collaboration